EUVIMEDEUVIMED entdecken
Open Access

Identification of a Novel PDRG1-EZH2-p21 Pathway Controlling Senescence and Tumor Progression in Hepatocellular Carcinoma

Qiang Yang, Lilong Zhang, Wei Li, Zhengle Zhang, Jing Tao, Yuping Rong, Weixing Wang

International Journal of Biological Sciences · 18.02.2026 · 22 (6) · 2827-2841

DOI: 10.7150/ijbs.129113 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Biological Sciences, erschienen am 18.02.2026. Verfasst von Qiang Yang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pancreatic Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei Province, China. Hauptthemen laut MEDLINE: Enhancer of Zeste Homolog 2 Protein, Liver Neoplasms, Carcinoma, Hepatocellular, Cyclin-Dependent Kinase Inhibitor p21. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatocellular carcinoma (HCC) remains a major global health burden with limited therapeutic options and poor prognosis. PDRG1 is upregulated in several malignancies, yet its clinical relevance and mechanistic role in HCC are not fully understood. Here, we investigated the contribution of PDRG1 to HCC progression and delineated the underlying molecular mechanism. Using public datasets, patient specimens, in vitro functional assays, and subcutaneous xenograft models, we evaluated PDRG1 expression, biological functions, and downstream pathways. Transcriptome profiling, pathway enrichment analysis, rescue experiments, co-immunoprecipitation, and ChIP-qPCR were performed to define the PDRG1-EZH2-p21 axis. PDRG1 was significantly upregulated in HCC tumor tissues compared with adjacent non-tumor liver tissues and was associated with worse patient survival. Functionally, PDRG1 enhanced HCC cell proliferation, migration, invasion, colony formation, and tumor growth in vivo. RNA-seq and enrichment analyses identified cellular senescence as a prominent downstream program regulated by PDRG1. Mechanistically, PDRG1 directly interacted with EZH2, increased H3K27me3 enrichment at the p21 promoter, and suppressed p21 transcription. Restoration of p21 expression attenuated the oncogenic effects of PDRG1, whereas EZH2 overexpression rescued the impaired malignant phenotypes caused by PDRG1 knockdown. Domain-mapping further indicated that the N-terminal residues 36-70 of PDRG1 contribute to its interaction with EZH2. Collectively, our findings identify PDRG1 as a clinically relevant oncogene in HCC and reveal an epigenetic mechanism by which PDRG1 cooperates with EZH2 to repress p21 and bypass senescence. The PDRG1-EZH2-p21 axis may represent a potential biomarker and therapeutic target for HCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Enhancer of Zeste Homolog 2 ProteinLiver NeoplasmsCarcinoma, HepatocellularCyclin-Dependent Kinase Inhibitor p21DNA-Binding ProteinsHumansAnimalsCellular SenescenceCell Line, TumorMiceGene Expression Regulation, NeoplasticCell ProliferationMice, Nude

Stichwörter der Autor:innen

EZH2PDRG1cellular senescencehepatocellular carcinomap21

Substanzen

Enhancer of Zeste Homolog 2 ProteinCyclin-Dependent Kinase Inhibitor p21EZH2 protein, humanDNA-Binding Proteins

Autor:innen und Institutionen

  • Department of Pancreatic Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei Province, China.
  • General Surgery Laboratory, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
  • Department of Hepatobiliary Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei Province, People's Republic of China.

Zitieren

APA

Yang, Q., Zhang, L., Li, W., Zhang, Z., Tao, J., Rong, Y., & Wang, W. (2026). Identification of a Novel PDRG1-EZH2-p21 Pathway Controlling Senescence and Tumor Progression in Hepatocellular Carcinoma. International Journal of Biological Sciences, 22(6), 2827-2841. https://doi.org/10.7150/ijbs.129113

Vancouver

Yang Q, Zhang L, Li W, Zhang Z, Tao J, Rong Y, et al. Identification of a Novel PDRG1-EZH2-p21 Pathway Controlling Senescence and Tumor Progression in Hepatocellular Carcinoma. International Journal of Biological Sciences. 2026;22(6):2827-2841. doi:10.7150/ijbs.129113

BibTeX
@article{Yang2026,
  author = {Yang, Qiang and Zhang, Lilong and Li, Wei and Zhang, Zhengle and Tao, Jing and Rong, Yuping and Wang, Weixing},
  title = {Identification of a Novel PDRG1-EZH2-p21 Pathway Controlling Senescence and Tumor Progression in Hepatocellular Carcinoma},
  journal = {International Journal of Biological Sciences},
  year = {2026},
  volume = {22},
  number = {6},
  pages = {2827--2841},
  doi = {10.7150/ijbs.129113}
}
Kostenlos starten →